Ex‑GOP lawmaker pushes friendshoring for drug supply
Former Rep. Cathy McMorris Rodgers has joined the U.S. Israel Education Association as a senior fellow to advise an initiative to 'friendshore' pharmaceutical supply chains away from China toward Abraham Accords partners (Israel, UAE, Bahrain and others). Rodgers told Fox News Digital the move responds to U.S. vulnerabilities—citing a Brookings estimate that Chinese APIs are present in about one‑quarter of drugs sold in the U.S.—and aims to shift production of active pharmaceutical ingredients and generics to allied countries when onshoring to the U.S. is not viable.
Politics
Health
International
📰 Sources (1)
Former Republican lawmaker looks to help US allies take power away from China
New information:
- Cathy McMorris Rodgers has joined USIEA as a senior fellow to advise on pharmaceutical friendshoring.
- Brookings Institution estimate cited: Chinese active pharmaceutical ingredients are included in ≈25% of drug volume sold in the U.S.
- Article notes generics represent about 92% of U.S. prescriptions, highlighting the scale of potential supply‑chain exposure; the initiative targets Abraham Accords countries (Israel, UAE, Bahrain, etc.).